Tick-borne pulmonary disease: Update on diagnosis and management

Chest

Volumn 116, Issue 1, 1999, Pages 222-230

  Faul, John L ^a   Doyle, Ramona L ^a   Kao, Peter N ^a   Ruoss, Stephen J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ehrlichia; Lyme; Pulmonary; Respiratory; Tick; Tularemia

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; NEUROTOXIN; QUINIDINE;

ANTIBIOTIC THERAPY; BABESIOSIS; BORRELIA INFECTION; CLINICAL FEATURE; COLORADO TICK FEVER; DISEASE CARRIER; EHRLICHIOSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG COMPLICATION; LYME DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; ROCKY MOUNTAIN SPOTTED FEVER; THORAX RADIOGRAPHY; TICK BITE; TICK BORNE DISEASE; TULAREMIA;

EID: 0032779006     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.1.222     Document Type: Article

References (95)

1. 1 Lyme disease - US, 1987 and 1988. MMWR Morb Mortal Wkly Rep 1989; 38:668-672
2. 2 Spach DH, Liles WC, Campbell GL, et al. Tick-borne diseases in the US. N Engl J Med 1993; 329:936-947
3. 3 Myers SA, Sexton DJ. Dermatologic manifestations of arthropod-borne diseases [review]. Infect Dis Clin North Am 1994; 8(3):689-712
4. 4 Cary NRB, Fox B, Wright DJM, et al. Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node. Postgrad Med 1990; 66:134-136
5. 5 Paddock CD, Sumner JW, Shore GM, et al. Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol 1997; 10:2496-2502
6. 6 Hardalo CJ, Quagliarello V, Dumler JS. Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin Infect Dis 1995; 4:910-914
7. 7 Kirsch M, Ruben FL, Steere AC, et al. Fatal adult respiratory distress syndrome in a patient with Lyme disease. JAMA 1988; 259:2737-2739
8. 8 Middleton DB. Tick-borne infections: what starts as a tiny bite may have a serious outcome. Postgrad Med 1994; 5:131-139
9. 9 Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995; 333:1319-1327
10. 10 Strle F, Maraspin V, Lotric-Fulan S, et al. Epidemiologic study of a cohort of adult patients with erythema migrans registered in Slovenia in 1993. Eur J Epidemiol 1996; 5:503-507
11. 11 Sonenshine DE, Azad AF. Ticks and mites in disease transmission. In: Strickland GT, ed. Hunter's tropical medicine. 7th ed. Philadelphia, PA: WB Saunders, 1991; 971-981
12. 12 Peavy CA, Lane RS, Kleinjan JE. Role of small mammals in the ecology of B. burgdorferi in a peri-urban park in north coastal California. Exp Appl Acarol 1997; 21:569-584
13. 13 Fritz CL, Kjemtrup AM, Conrad PA, et al. Seroepidemiology of emerging tick-borne infectious diseases in a northern Californian community. J Infect Dis 1997; 175:1432-1439
14. 14 Oksi J, Viljanen MK, Kalimo H, et al. Fatal encephalitis caused by concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi. Clin Infect Dis 1993; 16:392-396
15. 15 Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease: a tick-borne spirochetosis? Science 1982; 216:1317-1319
16. 16 Steere AC. Lyme disease. N Engl J Med 1989; 321:586-596
17. 17 Piesman J, Happ CM. Ability of the Lyme disease spirochaete B. burgdorferi to infect rodents and three species of human-biting ticks (black-legged tick, American dog tick, lone star tick). J Med Entomol 1997; 4:451-456
18. 18 Lyme disease - US, 1991-1992. MMWR Morb Mortal Wkly Rep 1993; 42:345-348
19. 19 Hansen K, Lebach AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. Brain 1992; 115:399-423
20. 20 de Mik EL, van Pelt W, Docters-van Leeuwen BD, et al. The geographical distribution of tick bites and erythema migrans in general practice in the Netherlands. Int J Epidemiol 1997; 2:451-457
21. 21 Steere AC, Grodzichi RL, Kornblatt AN, et al. The spirochaetal etiology of Lyme disease. N Engl J Med 1983; 308:733-742
22. 22 Piesman J, Maupin GO, Campos EG, et al. Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method. J Infect Dis 1991; 163:895-897
23. 23 Berger BW. Dermatologic manifestations of Lyme disease. Rev Infect Dis 1989; II(suppl):S1475-S1481
24. 24 Byrd RP, Vasquez J, Roy TM. Respiratory manifestations of tick-borne diseases in the southern US. South Med J 1997; 90:1-4
25. 25 Halperin JJ, Little BW, Coyle PK, et al. Lyme disease: cause of a treatable peripheral neuropathy. Neurology 1987; 37: 1700-1706
26. 26 Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990; 323: 1438-1444
27. 27 Krishnamurthy KB, Liu GT, Logigian EL. Acute Lyme neuropathy presenting with polyradicular pain, abdominal protusion and cranial neuropathy. Muscle Nerve 1993; 16: 1261-1264
28. 28 Silva MT, Sophar M, Howard RS, et al. Neuroborreliosis as a cause of respiratory failure. J Neurol 1995; 242:604-607
29. 29 Faul JL, Ruoss S, Doyle RL, et al. Diaphragmatic paralysis due to Lyme disease. Eur Respir J 1999; 13:700-702
30. 30 Marcus LC, Steere AC, Duray PH, et al. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis: demonstration of spirochaetes in the myocardium. Ann Intern Med 1985; 103:374-376
31. 31 Mayer W, Kleber FX, Wilske B, et al. Persistent atrioventricular block in Lyme borreliosis. Klin Wochenschr 1990; 68:431-435
32. 32 Cox J, Krajden M. Cardiovascular manifestations of Lyme disease [review]. Am Heart J 1991; 122:1499-1555
33. 33 Rubin DA, Sorbera C, Nikitin P, et al. Prospective evaluation of heart block complicating early Lyme disease. PACE 1992; 15:252-255
34. 34 Steere AC, Batsford WP, Weinberg M, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 1980; 93:8-16
35. 35 van der Linde MR. Lyme carditis: clinical characteristics of 105 cases. Scand J Infect Dis Suppl 1991; 77:81-84
36. 36 de Koning J, Hoogkamp-Korstanje JAA, van der Linde MR, et al. Demonstration of spirochetes in cardiac biopsies of patients with Lyme disease. J Infect Dis 1989; 160:150-153
37. 37 Stanek G, Klein J, Bittner R, et al. Borrelia burgdorferi as an etiologic agent in chronic heart failure? Scand J Infect Dis Suppl 1991; 77:85-87
38. 38 Stanek G, Klein J, Bittner R, et al. Isolation of B burgdorferi from the myocardium of a patient with long-standing cardiomyopathy. N Engl J Med 1990; 322:249-252
39. 39 Nagi KS, Joshi R, Thakur RK. Cardiac manifestations of Lyme disease: a review [review]. Can J Cardiol 1996; 12:503-506
40. 40 Dressler F, Whalen JA, Reinhardt BN, et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167:392-400
41. 41 Meurice F, Parenti D, Fu D, et al. Specific issues in the design and implementation of an efficacy trial for Lyme disease vaccine. Clin Infect Dis 1997; 25(suppl): S71-S75
42. 42 Wormser GP. Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination. Semin Neurol 1997; 17:45-52
43. 43 Schutzer SE, Brown T Jr, Holland BK. Reduction of Lyme disease exposure by recognition and avoidance of high-risk areas [letter]. Lancet 1997; 349:1668
44. 44 Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 1997; 337:289-294
45. 45 Eckman MH, Steere AC, Kalish RA, et al. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med 1997; 337:357-363
46. 46 Rocky Mountain spotted fever - US, 1990. MMWR Morb Mortal Wkly Rep 1991; 40:451-459
47. 47 Salgo MP, Telzak EE, Currie B, et al. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med 1988; 318:1345-1348
48. 48 Mc Dade JE, Newhouse VF. Natural history of Rickettsia rickettsii. Annu Rev Microbiol 1986; 40:287-309
49. 49 Walker DH. Rickettsioses of the spotted fever group around the world. J Dermatol 1989; 3:169-177
50. 50 Raoult D, Zuchelli P, Weiller PJ, et al. Incidence, clinical observations and risk factors in the severe form of Mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984. J Infect 1986; 12:111-116
51. 51 Donohue JF. Lower respiratory tract involvement in Rocky Mountain spotted fever. Arch Intern Med 1980; 140:223-227
52. 52 Sacks HS, Lyons RW, Lahiri B. Adult respiratory distress syndrome in Rocky Mountain spotted fever. Am Rev Respir Dis 1981; 123:547-549
53. 53 Woodward TE, Pedersen CE Jr, Oster CN, et al. Prompt confirmation of Rocky Mountain spotted fever: identification of rickettsiae in skin tissues. J Infect Dis 1976; 134:297-301
54. 54 Wisseman CL Jr, Ordonex SV. Actions of antibiotics on Rickettsia rickettsii. J Infect Dis 1986; 153:626-628
55. 55 Kostman JR. Laboratory diagnosis of rickettsial diseases. Clin Dermatol 1996; 14:301-306
56. 56 Kamper CA, Chessman KH, Phelps SJ. Rocky Mountain spotted fever. Clin Pharm 1988; 7:109-116
57. 57 Maurin M, Raoult D. Bacteriostatic and bacteriocidal actions of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetti. J Antimicrob Chemother 1997; 39:725-730
58. 58 Maeda K, Markowitz N, Hawley RC, et al. Human infection with Ehrlichia canis, a leucocytic rickettsia. N Engl J Med 1987; 316:853-856
59. 59 Standaert SM, Dawson JE, Schaffner W, et al. Ehrlichiosis in a golf-oriented retirement community. N Engl J Med 1995; 333:420-425
60. 60 Broavi P, Dumler JS, Lienhard R, et al. Human granulocytic ehrlichiosis in Europe. Lancet 1995; 346:782-783
61. 61 Bakken JS, Dumler JS, Chen SM, et al. Human granulocytic ehrlichiosis in upper Midwest United States: a new species emerging? JAMA 1994; 272:212-218
62. 62 Bakken JS, Krueth J, Tilden RL, et al. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur J Clin Microbiol Infect Dis 1996; 15:829-832
63. 63 Eng TR, Harkess JR, Fishbein DB, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 1990; 264:2251-2258
64. 64 Vugia DJ, Holmberg E, Steffe EM, et al. A human case of monocytic ehrlichiosis with ARDS in northern California. West J Med 1996; 164:525-528
65. 65 Paparone PW, Ljubich P, Rosman GA, et al. Ehrlichiosis with pancytopenia and ARDS. N J Med 1995; 92:381-385
66. 66 McCoy GW, Chapin CW. Further observations on a plaque-like disease of rodents with a preliminary note on the causative agent, bacterium Tularense. J Infect Dis 1912; 10:61-72
67. 67 Tarnvik A, Sandstrom G, Sjostedt A. Infrequent manifestations of tularaemia in Sweden. Scand J Infect Dis 1997; 29:443-446
68. 68 Gurycova D. Analysis of the incidence and routes of transmission of tularaemia in Slovakia. Epidemiol Mikrobiol Immunol 1997; 46:67-72
69. 69 Taylor JP, Istre GR, McChesney TC, et al. Epidemiologic characteristics of human tularaemia in the southwest-central states, 1981-1987. Am J Epidemiol 1991; 133:1032-1038
70. 70 Avery FW, Barnett TB. Pulmonary tularaemia: a report of five cases and consideration of pathogenesis and terminology. Am Rev Respir Dis 1967; 95:584-591
71. 71 Weinberg AN. Respiratory infections transmitted from animals. Infect Dis Clin North Am 1991; 5:649-661
72. 72 Evans ME, Gregory DW, Schaffner W, et al. Tularaemia: a 30-year experience with 88 cases. Medicine 1985; 64:251-269
73. 73 Gill V, Cunha BA. Tularaemia pneumonia. Semin Respir Infect 1997; 12:61-67
74. 74 Rubin SA. Radiographic spectrum of pleuropulmonary tularaemia. AJR Am J Roentgenol 1978; 131:277-281
75. 75 Miller RP, Bates JH. Pleuropulmonary tularaemia: a review of 29 patients. Am Rev Respir Dis 1983; 148:63-67
76. 76 Schmid GP, Kornblatt AN, Connors CA, et al. Clinically mild tularaemia associated with tick-borne Franciscella tularensis. J Infect Dis 1983; 148:63-67
77. 77 Mason WL, Eigelsbach HT, Little SF, et al. Treatment of tularaemia, including pulmonary tularaemia with gentamicin. Am Rev Respir Dis 1980; 121:39-45
78. 78 Burke DS. Immunization against tularaemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularaemia. J Infect Dis 1977; 135:55-60
79. 79 Goodpasture HC, Poland JD, Francy B, et al. Colorado tick fever: clinical epidemiologic, and laboratory aspects of 228 cases in Colorado in 1973-1974. Ann Intern Med 1978; 88:303-310
80. 80 Davis RD, Burke JP, Wright LJ. Relapsing fever associated with ARDS in a parturient woman: a case report and review of the literature. Chest 1991; 102:630-632
81. 81 Boustani MR, Lepore TJ, Gelfand JA, et al. Acute respiratory failure in patients treated for babesiosis. Am J Respir Crit Care Med 1994; 149:1689-1691
82. 82 Horowitz ML, Coletta F, Fein AM. Delayed onset adult respiratory distress syndrome in babesiosis. Chest 1994; 106:1299-1301
83. 83 Gordon S, Cordon RA, Mazdzer EJ, et al. Adult respiratory distress syndrome in babesiosis. Chest 1984; 86:633-634
84. 84 Meldrum SC, Birkhead GS, White DJ, et al. Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis 1992; 15:1019-1023
85. 85 Gombert ME, Goldstein EJ, Benach JL, et al. Human babesiosis: clinical and therapeutic considerations. JAMA 1982; 248:3005-3007
86. 86 Ruebush TK II, Chisholm ES, Sulzer AJ, et al. Development and persistence of antibody in persons infected with Babesia microti. Am J Trop Med Hyg 1981; 30:291-292
87. 87 Gothe R, Kunze K, Hoogstraal H. The mechanisms of pathogenicity in the tick paralyses. J Med Entomol 1979; 16:357-369
88. 88 Gorman RJ, Snead OC. Tick paralysis in three children: the diversity of neurologic presentations. Clin Pediatr 1978; 17:249-251
89. 89 Grattan-Smith PJ, Morris JG, Johnston HM, et al. Clinical and neurophysiological features of tick paralysis. Brain 1997; 120:1975-1987
90. 90 Schmitt N, Bowmer EJ, Gregson JD. Tick paralysis in British Columbia. Can Med Assoc J 1969; 100:417-421
91. 91 Magnarelli LA, Andrealis TG, Stafford KG, et al. Rickettsiae and Borrelia burgdorferi in ixodid ticks. J Clin Microbiol 1991; 29:2798-2804
92. 92 Fix AD, Strickland GT, Grant J. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. JAMA 1998; 279:206-210
93. 93 Ahkee S, Ramirez J. A case of concurrent Lyme meningitis with Ehrlichiosis. Scand J Infect Dis 1996; 28:527-528
94. 94 Dumler JS, Doterall L, Gustafson R, et al. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden. J Infect Dis 1997; 175:720-722
95. 95 Magnarelli LA, Dumler JS, Anderson JF, et al. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis and Lyme borreliosis in human sera. J Clin Microbiol 1995; 33:3054-3057